Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zied Kaabia"'
Autor:
Zied Kaabia, Julie Poirier, Michelle Moughaizel, Audrey Aguesse, Stéphanie Billon-Crossouard, Fanta Fall, Manon Durand, Elie Dagher, Michel Krempf, Mikaël Croyal
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Abstract Cardiovascular diseases are often associated with impaired lipid metabolism. Animal models are useful for deciphering the physiological mechanisms underlying these pathologies. However, lipid metabolism is contrasted between species limiting
Externí odkaz:
https://doaj.org/article/25a85a0f641043e1a07b9447ba5badf4
Autor:
Chloé Cloteau, Gaud Dervilly, Zied Kaabia, Florian Bagilet, Vivian Delcourt, Benoit Loup, Yann Guitton, Anne‐Lise Royer, Fabrice Monteau, Patrice Garcia, Marie‐Agnès Popot, Bruno Le Bizec, Ludovic Bailly‐Chouriberry
Publikováno v:
Drug Testing and Analysis. 14:864-878
In order to overcome the challenge associated with the screening of Anabolic-Androgenic Steroids abuses in animal competitions, a non-targeted liquid chromatography coupled to high resolution mass spectrometry based metabolomics approach was implemen
Autor:
Zied Kaabia, Ludovic Bailly-Chouriberry, Marie-Agnès Popot, Sébastien Rouger, Vivian Delcourt, Patrice Garcia, Yves Moulard, Karine Dauriac, Benoit Loup, Stéphane Trevisiol, Ruediger Narbe, Sophie Boyer, Guillaume Groseille
Publikováno v:
Drug Testing and Analysis. 14:252-261
Ciclesonide (CIC) is the first inhaled highly potent corticosteroid which does not cause any cortisol suppression. It has been developed for the treatment of asthma in human and more recently in equine. CIC is the active compound of Aservo® EquiHale
Autor:
Chloé Cloteau, Gaud Dervilly, Benoit Loup, Zied Kaabia, Vivian Delcourt, Florian Bagilet, Guillaume Groseille, Karine Dauriac, Sabrina Fisher, Marie-Agnès Popot, Patrice Garcia, Bruno Le Bizec, Ludovic Bailly-Chouriberry
Despite their ban, Anabolic Androgenic Steroids (AAS) are considered as the most important threat for equine doping purposes. In the context of controlling such practices in horse racing, metabolomics has emerged as a promising alternative strategy t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84da97a4fc7e0cb69eca4bfaa3c47169
https://doi.org/10.21203/rs.3.rs-1824805/v1
https://doi.org/10.21203/rs.3.rs-1824805/v1
Autor:
Marjaana Viljanto, Zied Kaabia, Polly Taylor, Tessa Muir, Jocelyn Habershon‐Butcher, Ludovic Bailly‐Chouriberry, James Scarth
Publikováno v:
Drug testing and analysisREFERENCES. 14(5)
Boldenone is an anabolic-androgenic steroid that is prohibited in equine sports. However, in certain situations, it is endogenous or is believed to be formed by microbes in urine, and therefore, an approach for the differentiation is required. Follow
Autor:
Gilles Lambert, Thomas Baty, Stéphanie Billon-Crossouard, Zied Kaabia, Stéphane Ramin-Mangata, Tim Hollstein, Michel Krempf, Audrey Aguesse, Mikaël Croyal, Fanta Fall, David R. Sullivan, Luis León, E. Nobecourt
Publikováno v:
Journal of Diabetes & Metabolism
Journal of Diabetes & Metabolism, OMICS International, 2018, 44 (2), pp.143-149. ⟨10.1016/j.diabet.2017.04.003⟩
Journal of Diabetes & Metabolism, OMICS International, 2018, 44 (2), pp.143-149. ⟨10.1016/j.diabet.2017.04.003⟩
International audience; AimThe benefit of the lipid-lowering drug fenofibrate on cardiovascular outcomes is controversial. Our aim was to find new circulating markers to identify those patients most likely to benefit from fenofibrate prescription.Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e06aaabef81294b1f0869a19d0a211
https://hal.archives-ouvertes.fr/hal-02429551
https://hal.archives-ouvertes.fr/hal-02429551
Autor:
Zied Kaabia, Aruna S. Prakash, David Parker, Anthony W. T. Bristow, Ci Yan, Peter Stokes, Jackie A. Mosely, Michael P. Smith, Martin Sims, Glenn A. Hurst
Publikováno v:
Journal of the American Society for Mass Spectrometry. 23:850-857
LC ESI FTICR MS of a sample of cediranib identified this pharmaceutical target molecule plus an additional 10 compounds of interest, all of which were less than 10% total ion current (TIC) peak intensity relative to cediranib. LC FTICR tandem mass sp